Department of Nephrology, Chutoen General Medical Center, Shizuoka, Japan.
PLoS One. 2022 Jun 24;17(6):e0269849. doi: 10.1371/journal.pone.0269849. eCollection 2022.
A higher body mass index (BMI) has been associated with better survival among chronic kidney disease patients in some reports. However, more research is required to determine the associations between BMI and mortality in incident hemodialysis patients. Therefore, this study aimed to investigate the association between mortality and BMI measured at the first hemodialysis session and 2 weeks after hemodialysis initiation in Japanese patients with incident hemodialysis.
We retrospectively enrolled 266 adult patients with incident hemodialysis who were treated at our hospital between May 2013 and June 2019. The data on BMI was obtained at the first hemodialysis session and 2 weeks after hemodialysis initiation. Patients were divided into tertiles based on BMI [<18.5 (low), 18.5-23.9 (normal), and ≥24 (high) kg/m2]. The normal group was used as the reference group. The primary outcome was all-cause mortality.
The mean age of patient was 68.9 ± 12.0 years, and the BMI was 23.3 ± 4.24 kg/m2 at the first hemodialysis session. The body mass index was 22.0 ± 3.80 kg/m2 at 2 weeks after hemodialysis initiation. During a mean follow-up of 3.89 ± 2.12 years, 80 (30.1%) deaths occurred. In multivariate analyses, low BMI at the first hemodialysis session was significantly associated with worse all-cause mortality (hazard ratio, 2.39; 95% confidence interval, 1.13-5.03). At 2 weeks after hemodialysis initiation, high BMI was significantly associated with better all-cause mortality (hazard ratio, 0.38; 95% confidence interval, 0.18-0.81).
At 2 weeks after HD initiation, high BMI was associated with lower mortality in Japanese patients with incident hemodialysis.
一些报告显示,较高的体重指数(BMI)与慢性肾脏病患者的生存改善相关。然而,需要更多的研究来确定 BMI 与起始血液透析患者死亡率之间的关系。因此,本研究旨在调查日本起始血液透析患者中首次血液透析时和起始血液透析后 2 周时 BMI 与死亡率之间的关系。
我们回顾性纳入了 2013 年 5 月至 2019 年 6 月在我院接受治疗的 266 例成人起始血液透析患者。BMI 数据在首次血液透析时和起始血液透析后 2 周获得。根据 BMI 将患者分为三分位组[<18.5(低)、18.5-23.9(正常)和≥24(高)kg/m2]。以正常组为参考组。主要结局为全因死亡率。
患者的平均年龄为 68.9±12.0 岁,首次血液透析时的 BMI 为 23.3±4.24kg/m2,起始血液透析后 2 周时的 BMI 为 22.0±3.80kg/m2。在平均 3.89±2.12 年的随访期间,有 80 例(30.1%)死亡。多变量分析显示,首次血液透析时的低 BMI 与全因死亡率较差显著相关(风险比,2.39;95%置信区间,1.13-5.03)。起始血液透析后 2 周时,高 BMI 与全因死亡率较低显著相关(风险比,0.38;95%置信区间,0.18-0.81)。
起始血液透析后 2 周时,高 BMI 与日本起始血液透析患者的死亡率降低相关。